These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 32150897)
1. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Constâncio V; Nunes SP; Henrique R; Jerónimo C Cells; 2020 Mar; 9(3):. PubMed ID: 32150897 [TBL] [Abstract][Full Text] [Related]
2. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel. Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction. Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064 [TBL] [Abstract][Full Text] [Related]
4. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738 [TBL] [Abstract][Full Text] [Related]
5. COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR. Overs A; Peixoto P; Hervouet E; Molimard C; Monnien F; Durand J; Guittaut M; Vienot A; Viot J; Herfs M; Borg C; Feugeas JP; Selmani Z Clin Epigenetics; 2024 Oct; 16(1):146. PubMed ID: 39425144 [TBL] [Abstract][Full Text] [Related]
6. The Significance of Circulating Tumour Cells in the Clinic. Abalde-Cela S; Piairo P; Diéguez L Acta Cytol; 2019; 63(6):466-478. PubMed ID: 30820013 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer. Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer and liquid biopsies: Clinical applications and challenges. Urabe F; Sumiyoshi T; Tashiro K; Goto T; Kimura T; Kobayashi T Int J Urol; 2024 Jun; 31(6):617-626. PubMed ID: 38551314 [TBL] [Abstract][Full Text] [Related]
9. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients. Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654 [TBL] [Abstract][Full Text] [Related]
10. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study. Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158 [TBL] [Abstract][Full Text] [Related]
11. Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies. Haldrup C; Pedersen AL; Øgaard N; Strand SH; Høyer S; Borre M; Ørntoft TF; Sørensen KD Mol Oncol; 2018 Apr; 12(4):545-560. PubMed ID: 29465788 [TBL] [Abstract][Full Text] [Related]
12. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation. Gao Y; Zhou N; Liu J Cancer Control; 2024; 31():10732748241255548. PubMed ID: 38764160 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation drives a new path in gastric cancer early detection: Current impact and prospects. Wang X; Dong Y; Zhang H; Zhao Y; Miao T; Mohseni G; Du L; Wang C Genes Dis; 2024 Mar; 11(2):847-860. PubMed ID: 37692483 [TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267 [TBL] [Abstract][Full Text] [Related]
15. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer. Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249 [TBL] [Abstract][Full Text] [Related]
16. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study. Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456 [TBL] [Abstract][Full Text] [Related]
17. Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook. Lianidou E Mol Oncol; 2021 Jun; 15(6):1683-1700. PubMed ID: 33942482 [TBL] [Abstract][Full Text] [Related]
18. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan. Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma. Cao M; Zhang C; Zhou L Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810 [TBL] [Abstract][Full Text] [Related]
20. Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer. Lin YL; Li YL; Ma JG Med Sci Monit; 2017 Oct; 23():4895-4900. PubMed ID: 29026066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]